![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/22/2866906/0/en/VIVUS-Announces-it-will-Provide-Telehealth-to-Patients-through-an-Enhanced-Engage-Program-in-Collaboration-with-UpScriptHealth.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022523
https://www.globenewswire.com//news-release/2024/01/08/2805507/0/en/VIVUS-Provides-Update-on-Pipeline-and-Program-Milestones.html
https://www.globenewswire.com//news-release/2023/11/28/2787056/0/en/New-Clinical-Data-Demonstrate-that-QSYMIA-the-Leading-Once-Daily-Oral-Weight-Management-Medication-Reduces-Blood-Pressure.html
https://www.globenewswire.com/news-release/2023/05/17/2670696/0/en/VIVUS-QSIVA-in-Combination-with-a-Digital-Lifestyle-Intervention-Leads-to-Significant-Weight-Loss-and-Decreased-Cardiovascular-Risk-in-Patients-with-Obesity.html
https://www.globenewswire.com/news-release/2023/01/10/2586253/0/en/VIVUS-Announces-Key-Management-Updates-to-Support-Global-Expansion-Strategy.html
https://endpts.com/icer-reaffirms-qsymia-as-most-cost-effective-obesity-treatment-in-final-report/
https://www.prnewswire.com/news-releases/petros-pharmaceuticals-partners-with-leading-global-contract-manufacturer-to-bring-production-of-erectile-dysfunction-drug-stendrao-avanafil-to-the-united-states-301466260.html
https://www.globenewswire.com/news-release/2020/07/07/2058956/0/en/VIVUS-Completes-Solicitation-for-In-Court-Reorganization-Plan-to-Become-a-Wholly-Owned-Subsidiary-of-IEH-Biopharma-LLC.html#:~:text=(Nasdaq%3A%20VVUS%3B%20the%20%E2%80%9C,7%2C%202020%20chapter%2011%20filing.